Search hospitals > Colorado > Longmont
Rocky Mountain Cancer Centers-Longmont
Claim this profileLongmont, Colorado 80501
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Adenocarcinoma
Conducts research for Non-Small Cell Lung Cancer
192 reported clinical trials
7 medical researchers
Summary
Rocky Mountain Cancer Centers-Longmont is a medical facility located in Longmont, Colorado. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Rocky Mountain Cancer Centers-Longmont is involved with conducting 192 clinical trials across 399 conditions. There are 7 research doctors associated with this hospital, such as Richard L. Deming, Nicholas DiBella, David J Andorsky, and Robert M. Jotte.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage I
Top PIs
Richard L. DemingMercy Medical Center - Des Moines4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
172 reported clinical trials
239 drugs studied
Nicholas DiBellaRocky Mountain Cancer Centers-Boulder5 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
103 reported clinical trials
193 drugs studied
David J AndorskyRocky Mountain Cancer Centers USOR3 years of reported clinical research
Studies Leukemia
Studies Myeloid Leukemia
9 reported clinical trials
13 drugs studied
Robert M. JotteGSK Investigational Site3 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
6 reported clinical trials
11 drugs studied
Clinical Trials running at Rocky Mountain Cancer Centers-Longmont
Breast Cancer
Bladder Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Bladder Carcinoma
Anal Cancer
Squamous Cell Carcinoma
Multiple Myeloma
Urothelial Carcinoma
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Marker-Directed Monitoring
for Breast Cancer
This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.
Recruiting1 award N/A
Cognitive Training
for Breast Cancer Survivors
This Phase III trial will examine the efficacy of computerized cognitive training methods on perceived cognitive impairment in breast cancer survivors.
Recruiting1 award N/A5 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Rocky Mountain Cancer Centers-Longmont?
Rocky Mountain Cancer Centers-Longmont is a medical facility located in Longmont, Colorado. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Rocky Mountain Cancer Centers-Longmont is involved with conducting 192 clinical trials across 399 conditions. There are 7 research doctors associated with this hospital, such as Richard L. Deming, Nicholas DiBella, David J Andorsky, and Robert M. Jotte.